← Back
$ETON All transactions

Eton Pharmaceuticals, Inc.

A

$ Value

$0

Shares

40,655

Price

$0

Filed

Jan 14

Insider

Name

Krempa David

Title

Chief Business Officer

CIK

0001968254

Roles

Officer

Transaction Details

Transaction Date

2026-01-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

670,893

Footnotes

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units. | The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. | The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030. | Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock. | The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Filing Info

Accession No.

0001437749-26-001288

Form Type

4

Issuer CIK

0001710340

Krempa David's History

Date Ticker Type Value
2026-01-14 ETON F $30K
2026-01-12 ETON A $0
2026-01-12 ETON A $0
2025-12-12 ETON F $106K
2025-12-11 ETON A $0
2025-06-16 ETON $151K
2025-06-13 ETON $100K
2025-06-12 ETON $253K

Other Insiders at ETON (90d)

Insider Bought Sold Last
RIEDEL NORBERT G 2026-04-21